Cargando…
Validation of an Objective Measure of Dry Eye Severity
PURPOSE: We evaluated the validity of a single dry eye severity measure estimated using Rasch analysis from a battery of clinical tests and patient symptoms. METHODS: This study included 203 dry eye patients and 51 controls. Administered tests included the Ocular Surface Disease Index (OSDI), tear o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183328/ https://www.ncbi.nlm.nih.gov/pubmed/30323999 http://dx.doi.org/10.1167/tvst.7.5.26 |
_version_ | 1783362698660020224 |
---|---|
author | Karakus, Sezen Akpek, Esen K. Agrawal, Devika Massof, Robert W. |
author_facet | Karakus, Sezen Akpek, Esen K. Agrawal, Devika Massof, Robert W. |
author_sort | Karakus, Sezen |
collection | PubMed |
description | PURPOSE: We evaluated the validity of a single dry eye severity measure estimated using Rasch analysis from a battery of clinical tests and patient symptoms. METHODS: This study included 203 dry eye patients and 51 controls. Administered tests included the Ocular Surface Disease Index (OSDI), tear osmolarity, Schirmer's test, noninvasive break-up time, and ocular surface staining. Each of the 12 OSDI questions and each clinical test was defined to be a separate indicator to estimate a single dry eye severity measure from Rasch analysis. Measures of severity were estimated for each subject (person measures) and measures of sensitivity to severity were estimated for each sign and symptom (indicator measures). RESULTS: The average severity measure for dry eye patients was significantly greater than the average severity measure for controls (−0.39 vs. −1.2, P < 0.001). The distribution of indicator measures was well matched to the distribution of person measures. No indicator carried >10% of the total information about dry eye severity carried by all indicators together. However, the most informative indicators were corneal and conjunctival staining. CONCLUSIONS: Our study indicated that there is no single “best” dry eye test. Clinical tests and symptoms should be used in combination to estimate a single dry eye severity measure. TRANSLATIONAL RELEVANCE: There is no single “gold standard” testing method for dry eye that correlates with the severity of disease. We propose that Rasch analysis can be used to calculate an objective dry eye severity score from a battery of clinical indicators. |
format | Online Article Text |
id | pubmed-6183328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-61833282018-10-15 Validation of an Objective Measure of Dry Eye Severity Karakus, Sezen Akpek, Esen K. Agrawal, Devika Massof, Robert W. Transl Vis Sci Technol Articles PURPOSE: We evaluated the validity of a single dry eye severity measure estimated using Rasch analysis from a battery of clinical tests and patient symptoms. METHODS: This study included 203 dry eye patients and 51 controls. Administered tests included the Ocular Surface Disease Index (OSDI), tear osmolarity, Schirmer's test, noninvasive break-up time, and ocular surface staining. Each of the 12 OSDI questions and each clinical test was defined to be a separate indicator to estimate a single dry eye severity measure from Rasch analysis. Measures of severity were estimated for each subject (person measures) and measures of sensitivity to severity were estimated for each sign and symptom (indicator measures). RESULTS: The average severity measure for dry eye patients was significantly greater than the average severity measure for controls (−0.39 vs. −1.2, P < 0.001). The distribution of indicator measures was well matched to the distribution of person measures. No indicator carried >10% of the total information about dry eye severity carried by all indicators together. However, the most informative indicators were corneal and conjunctival staining. CONCLUSIONS: Our study indicated that there is no single “best” dry eye test. Clinical tests and symptoms should be used in combination to estimate a single dry eye severity measure. TRANSLATIONAL RELEVANCE: There is no single “gold standard” testing method for dry eye that correlates with the severity of disease. We propose that Rasch analysis can be used to calculate an objective dry eye severity score from a battery of clinical indicators. The Association for Research in Vision and Ophthalmology 2018-10-10 /pmc/articles/PMC6183328/ /pubmed/30323999 http://dx.doi.org/10.1167/tvst.7.5.26 Text en Copyright 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Articles Karakus, Sezen Akpek, Esen K. Agrawal, Devika Massof, Robert W. Validation of an Objective Measure of Dry Eye Severity |
title | Validation of an Objective Measure of Dry Eye Severity |
title_full | Validation of an Objective Measure of Dry Eye Severity |
title_fullStr | Validation of an Objective Measure of Dry Eye Severity |
title_full_unstemmed | Validation of an Objective Measure of Dry Eye Severity |
title_short | Validation of an Objective Measure of Dry Eye Severity |
title_sort | validation of an objective measure of dry eye severity |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183328/ https://www.ncbi.nlm.nih.gov/pubmed/30323999 http://dx.doi.org/10.1167/tvst.7.5.26 |
work_keys_str_mv | AT karakussezen validationofanobjectivemeasureofdryeyeseverity AT akpekesenk validationofanobjectivemeasureofdryeyeseverity AT agrawaldevika validationofanobjectivemeasureofdryeyeseverity AT massofrobertw validationofanobjectivemeasureofdryeyeseverity |